Document Detail

Natural killer activity in hyperprolactinemic patients.
MedLine Citation:
PMID:  2807874     Owner:  NLM     Status:  MEDLINE    
Several pieces of evidence suggest the existence of a relationship between neuroendocrine and immune systems. Prolactin (PRL) has been demonstrated to modulate some immune responses and its influence seems to be permissive or inhibitory depending on its concentration. Previous studies have reported a reduced natural killer (NK) cell function in patients with hyperprolactinemia. In 36 patients (34 females and 2 males, aged 14-46 years) with hyperprolactinemia (mean +/- SEM PRL 142.2 +/- 42.1 micrograms/l) of tumorous (19 patients) and functional (17 patients) origins, NK activity of peripheral blood lymphocytes (PBL) was studied. Patients had NK cell activity against the K562 cell line which did not differ from that of lymphocytes from 36 age- and sex-matched healthy donors (mean +/- SEM lytic units (LU) 619.0 +/- 103.0 and 531.9 +/- 52.6 respectively). No correlation between PRL levels and LU values was found (r = 0.28). When patients with tumors or functional hyperprolactinemia were separately analysed no difference was found between these two groups (mean +/- SEM LU 690.0 +/- 117.7 vs. 606.0 +/- 148.8). In conclusion, our data demonstrate that neither the elevated PRL levels nor the PRL-secreting tumor per se interfere with the NK system of hyperprolactinemic patients.
L Matera; E Ciccarelli; A Cesano; F Veglia; C Miola; F Camanni
Related Documents :
15750834 - In vitro dendritic cell generation and lymphocyte subsets in myeloma patients: influenc...
6748044 - Induction of impaired activation of lymphocytes by suppressive factor in crohn's diseas...
9933434 - Successful immunomodulating in aids patients with ursodeoxycholic acid--a pilot study.
17923734 - Effects of gender on white blood cell populations and neutrophil-lymphocyte ratio follo...
3963944 - Clinical experience with timolol maleate monotherapy of hypertension.
23620634 - Head and neck cancer. an aetiopathogenetic study of non-endemic lymphoepithelioma.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Immunopharmacology     Volume:  18     ISSN:  0162-3109     ISO Abbreviation:  Immunopharmacology     Publication Date:    1989 Sep-Oct
Date Detail:
Created Date:  1989-12-21     Completed Date:  1989-12-21     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7902474     Medline TA:  Immunopharmacology     Country:  NETHERLANDS    
Other Details:
Languages:  eng     Pagination:  143-6     Citation Subset:  IM    
Istituto di Medicina Interna, Universita' di Torino, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Hyperprolactinemia / immunology*
Killer Cells, Natural / immunology*
Middle Aged
Neuroimmunomodulation / physiology
Prolactin / immunology
Reg. No./Substance:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Augmented macrophage PGE2 production following exposure to dimethylnitrosamine in vivo: relevance to...
Next Document:  Effect of bacterial purified antigenic fractions on natural defence mechanisms.